Home » Biotechnology » Oligonucleotide API Market

Oligonucleotide API Market By Type of Oligonucleotide (Antisense Oligonucleotides (ASOs), RNA Interference (RNAi) Oligonucleotides, Messenger RNA (mRNA) Oligonucleotides, Modified Oligonucleotides, Small Interfering RNA (siRNA) By Application (Rare Diseases, Oncology, Neurological Disorders, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases) -Growth, Future Prospects & Competitive Analysis, 2022 – 2030

Price: $4999

Published: | Report ID: 23006 | Report Format : PDF

Market Insights

  • The global demand for Oligonucleotide API was valued at USD 2315.5 million in 2022 and is expected to reach USD 5184.2 Million in 2030, growing at a CAGR of 10.60% between 2023 and 2030.
  • Antisense oligonucleotides are predicted to account for the majority of revenue by the end of 2035, while RNA Interference (RNAi) oligonucleotides contribute significantly to the Oligonucleotide API market.
  • Oncology is now the industry leader in the Oligonucleotide APIs market, and rare diseases are one of the Oligonucleotide API market’s fastest-growing categories.
  • Small oligonucleotides have gained significant market traction, while Long oligonucleotides contribute something fresh to the market.
  • Modified oligonucleotides are currently more popular than unmodified oligonucleotides.
  • Parenteral administration accounts for the majority of the Oligonucleotide API market, while oral administration is also important in the Oligonucleotide API business.
  • Pharmaceutical businesses are predicted to generate the highest revenue, followed by academic and research institutes.
  • North America dominates the Oligonucleotide API Market, accounting for around 45% of the global market share, while Europe is expected to grow at the fastest rate by the end of 2035.
  • Pharmaceutical businesses are expanding their R&D investments in order to increase market growth.
  • The high manufacturing costs of oligonucleotide APIs stifle market expansion.

Oligonucleotide API Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Executive Summary

Market Definition

The Oligonucleotide API Market is the industry that manufactures and distributes Active Pharmaceutical Ingredients (APIs) manufactured from oligonucleotides. Oligonucleotides are short nucleotide sequences utilized in a variety of therapeutic applications, including gene therapy, antisense therapy, and nucleic acid-based diagnostics. The market includes oligonucleotide-based API manufacture, research, and development, as well as commercialization.

Market Overview

It is anticipated that between 2023 and 2030, the worldwide Oligonucleotide API Market will expand at a compound annual growth rate (CAGR) of 10.60%. From USD 2315.5 million in 2022, the market is projected to be worth USD 5184.2 million by 2030.

Oligonucleotides are a versatile therapeutic technique with the potential to cure a wide range of diseases. In the pharmaceutical industry, antisense oligonucleotides, small/short interfering RNA, microRNA, immunostimulatory oligonucleotides, aptamers, and splice-switching oligonucleotides have garnered a lot of interest.

Oligonucleotide active pharmaceutical ingredients (APIs) are created by constructing the oligonucleotide chain one nucleotide at a time on a solid substrate. After completing the full sequence, the oligonucleotide is separated from the solid support and purified using chromatographic methods such as reverse phase or ion exchange chromatography.

The increase in laboratory and research institute experiments globally can be ascribed to the market’s expansion. The growing usage of oligonucleotides for a variety of applications such as gene editing, diagnostics, and therapies has fueled an increase in interest in APIs across businesses. According to World Bank data, there were 1597 researchers per 1,000,000 persons engaged in research and development activities worldwide in 2018, an increase from 1412 researchers per million in 2015. Furthermore, the increasing use of oligonucleotides in the effective treatment of a variety of illnesses is expected to drive market expansion throughout the forecast period.

In addition to these, factors considered to fuel oligonucleotide API market expansion include the worldwide increasing fraction of oligonucleotide API in the therapeutic pipeline, which is expected to accelerate the global oligonucleotide API market size in the approaching years. The oligonucleotide is a novel form of medicinal molecule that can be used to treat a wide range of ailments. To form a structure, oligonucleotide base pairs with DNA or RNA. Oligonucleotides are often used as primers in PCR (polymerase chain reaction). Furthermore, investments in high-profile large scientific projects, as well as funding for life science activities, novel product launches, and drug discovery, are likely to fuel demand for oligonucleotide API during the projection period.

Segmentation By Type of Oligonucleotide

  • Antisense oligonucleotides are expected to account for the majority of revenue by the end of 2035. The increasing focus on developing treatments for brain cancer and breast cancer, as well as increasing research on human genomics & proteomics, and related biotechnologies worldwide, are factors relevant to the segment’s growth, as is the investigation of the efficiencies of antisense for delivering effective results in the treatment.
  • RNA Interference (RNAi) oligonucleotides make a significant contribution to the Oligonucleotide API market. RNAi is a powerful mechanism that regulates gene expression by silencing specific genes through the use of oligonucleotides.

Segmentation By Application

  • Oncology is now the industry leader in Oligonucleotide APIs. The use of oligonucleotide APIs in cancer treatment, including as targeted treatments and gene silencing, has gotten a lot of interest and funding. This segment’s growth has been aided by the possibility for personalized treatment and precision oncology.
  • Rare diseases are one of the Oligonucleotide API market’s fastest-growing sectors. Oligonucleotide-based therapeutics provide novel prospects for treating uncommon genetic illnesses by targeting specific genomic targets. The capacity to target specific genes or mutations associated with uncommon diseases has yielded encouraging results, propelling this segment’s expansion.

Segmentation by Molecule Size

  • Small oligonucleotides, which typically range in length from 8 to 30 nucleotides, have garnered substantial market momentum. They are commonly employed in diagnostics, genetic research, and targeted medicines. Because of their small size, they can be delivered easily and efficiently to precise target sequences, making them essential instruments in precision medicine.
  • Long oligonucleotides, which typically exceed 30 nucleotides in length, bring something new to the market. They are frequently utilized in gene therapy, gene editing, and antisense medicines.

Segmentation by Modified vs. Unmodified Oligonucleotides

  • Modified oligonucleotides are currently more popular than unmodified oligonucleotides. Oligonucleotides that have been chemically changed improve their stability, specificity, and delivery capabilities.

Segmentation by Route of Administration

  • Parenteral administration holds the largest share of the Oligonucleotide API market. The API is injected directly into the body, bypassing the digestive system. Its benefits include quick and precise drug administration, making it a popular choice for many therapeutic applications.
  • Oral administration is important in the Oligonucleotide API industry. It entails ingesting the API orally, typically in the form of pills or capsules. While there may be issues with drug stability and absorption, oral administration provides ease, patient compliance, and the possibility of self-administration.

Segmentation by End-User

  • Pharmaceutical companies are expected to have the most revenue. The growing desire of pharmaceutical companies around the world to become self-sufficient, as well as increased drug research and development to provide efficient, cost-effective, and robust means of preventing and treating major diseases that plague the world, are expected to drive segment growth in the forecasted time frame.
  • Academic and research institutions is another key contributor to the market.

 Segmentation by Region

  • North America is the largest region in the Oligonucleotide API Market, accounting for around 45% of the worldwide market share.
  • Europe is predicted to grow at the quickest rate by the end of 2035.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Oligonucleotide API .

Oligonucleotide API Market Research

The oligonucleotide API market in North America is expected to generate the most revenue by the end of 2035. The region’s strong presence of the essential chemical ecosystem for pharmaceutical and biopharma firms, as well as rising R&D investments in drug discovery and commercialization, are projected to boost the regional market throughout the projection period. According to the US Food and Drug Administration (FDA), over 28% of API production facilities in 2019 were headquartered in the US, catering to the US and global markets. In addition, the rising frequency of cancer in North America, as well as growing worry about neurological disorders such as Alzheimer’s disease, which necessitate a tailored treatment, are likely to drive the regional market’s growth throughout the forecast period. According to National Cancer Institute estimates, about 1,806,590 new cancer cases will be diagnosed in the United States year 2020.

In addition, The Europe oligonucleotide API market is expected to grow at the fastest rate by the end of 2035. The growing government expenditure on healthcare, coupled with the rising burden of diseases and the region’s growing geriatric population, as well as the region’s many giant key players’ increasing focus on building an extensive pipeline for immunology treatment, is expected to boost regional market growth in the estimated time frame. The overall government expenditure on health in the European Union was estimated to be nearly USD 1,300 billion, or 8% of GDP, in 2020. Furthermore, because oligonucleotides are viewed as the next large group of therapeutics after biologics and molecules, these APIs are being tested for the treatment of neurological disorders, which are expected to boost market growth in the region in the given assessment years.

Key Highlights of the Report

The global Oligonucleotide API Market is segmented By Type of Oligonucleotide, End-Use Application, Molecule Size, Modified vs. Unmodified Oligonucleotides, Route of Administration, and region. Oncology has risen to the top of the Oligonucleotide APIs market. The Oligonucleotide API market is dominated by antisense oligonucleotides and parenteral administration. Furthermore, one of the Oligonucleotide API market’s fastest-growing sectors is rare disorders, with North America leading the market growth.

The primary drivers of the market include rising demand for personalized medicine and targeted therapies, advancements in oligonucleotide synthesis technologies and manufacturing processes, and rising investments in research & development of oligonucleotide-based therapeutics. Furthermore, the market is hampered by stringent regulatory requirements for oligonucleotide-based drug approval, high manufacturing costs associated with oligonucleotide APIs, and a lack of awareness and understanding of oligonucleotide-based therapies among healthcare professionals and patients.

Nonetheless, North America’s oligonucleotide API market is predicted to create the greatest revenue by the end of 2035. The region’s strong presence of the necessary chemical ecosystem for pharmaceutical and biopharma enterprises, as well as increased R&D investments in drug discovery and commercialization, are expected to drive the regional market over the forecast period. Furthermore, by the end of 2035, the Europe oligonucleotide API market is predicted to develop at the quickest rate.

What Elements Are Driving the Global Market for Oligonucleotide API ?

Oligonucleotide APIs are in high demand due to the increasing occurrence of uncommon diseases and the growing desire for tailored therapeutics. Also, advances in genetic research and personalized medicine are opening up possibilities for the creation of novel Oligonucleotide-based therapeutics. Rising investments in biotechnology and pharmaceutical research are also fueling industry expansion.

What Are The Main Obstacles That The Global Oligonucleotide API Market Faces?

Despite the potential benefits, the Oligonucleotide APIs industry has certain hurdles. Restriction factors include high development costs, difficult regulatory constraints, and restricted production capabilities. Moreover, the requirement for specialized knowledge and infrastructure for Oligonucleotide synthesis may impede market expansion.

What Market Development Prospects Are There For Oligonucleotide API Globally?

The Oligonucleotide APIs market offers numerous potential opportunities. The growing emphasis on precision medicine and the development of novel therapeutic techniques provide opportunities for market growth. Collaborations between pharmaceutical corporations and university research institutions, on the other hand, can lead to the identification of novel applications and breakthroughs in Oligonucleotide-based medicines.

Market Drivers

The global Oligonucleotide API Market is driven by several factors. The following are the key drivers of the global Oligonucleotide API Market:

Pharmaceutical companies are increasing their investment in R&D in order to boost market growth.

The key element ascribed to market expansion is an increase in pharmaceutical spending by pharmaceutical companies and government institutions worldwide, which is leading to the creation of new medication classes that can aid patients in the treatment of a wide range of disorders. The total spending on research and development in the pharmaceutical business was estimated to be slightly more than USD 230 billion in 2021.

Although most oligonucleotide therapeutics have been focused on gene silencing, prominent market players are persistently pursuing other strategies such as splice modulation and gene activation, expanding the range and accessibility of conventional pharmaceutical modalities, and developing high-quality oligonucleotide APIs that will facilitate new therapeutic strategies as these molecules have potential therapeutic applications for myria. As a consequence, the worldwide oligonucleotide API market is predicted to rise faster throughout the forecast period.

Market Restraints

The global Oligonucleotide API Market faces some challenges that may hinder its growth. These include the following:

High Manufacturing Costs Associated With Oligonucleotide APIs

The high production costs connected with oligonucleotide APIs are the enormous expenses involved in generating these specialty pharmaceutical components. Oligonucleotide APIs necessitate sophisticated synthesis procedures and demanding quality control systems, which raise manufacturing prices. Oligonucleotide synthesis frequently includes numerous processes, including purification and characterization, which can be time-consuming and resource-intensive. Additionally, the necessity for specific equipment and knowledge raises the cost. These high manufacturing costs might provide pricing and profitability issues for businesses.

However, as the demand for oligonucleotide-based medicines grows, attempts to optimize production methods and investigate cost-effective alternatives are underway. Technological advancements and scale-up capabilities may help reduce the impact of high production costs in the future, making oligonucleotide APIs more accessible and economical.

Opportunities

The global Oligonucleotide API Market offers significant growth opportunities. These include the following:

Expansion of Applications Beyond Traditional Therapeutic Areas

The possibility of expanding applications beyond traditional therapeutic domains refers to the possibility of using oligonucleotide APIs in new and diverse disciplines other than therapeutic treatments. Oligonucleotides have demonstrated remarkable possibilities in a variety of fields, including diagnostics, genetic research, and precision medicine. There is an opportunity to develop revolutionary applications in fields such as molecular diagnostics, gene editing, and targeted drug delivery systems by harnessing the unique features of oligonucleotides. This development opens the door to breakthroughs in customized medicine, as oligonucleotide APIs can be tuned to specific patient needs.

Furthermore, the investigation of oligonucleotide-based medicines in uncommon diseases and genetic disorders opens up new avenues for breakthrough treatments. As research into the potential of oligonucleotide APIs continues, the development of their uses into non-traditional therapeutic areas holds promise for advances in healthcare and science.

Competitive Landscape

Oligonucleotide API Market Report

Key Players

The global Oligonucleotide API Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Jazz Pharmaceuticals
  • Sarepta Therapeutics
  • Biogen
  • Dynavax Technologies
  • Akcea Therapeutics
  • Alnylam Pharmaceuticals
  • Nitto Denko (Avecia)
  • Ajinomoto (GeneDesign)
  • RiboBio

These organizations prioritize product innovation, Disease Area expansion, and mergers and acquisitions to stay competitive.

The global Oligonucleotide API Market’s key players continually seek to stay ahead by offering new Speciess and developments.

In June 2021, Ionis Pharmaceuticals, Inc., a biotechnology company, and Biogen Inc. recently announced the findings of a study on the use of antisense oligonucleotide (ASO) for persons with C9orf72-associated amyotrophic lateral sclerosis (ALS).

In January 2021, Jazz Pharmaceuticals plc, an Irish biopharmaceutical company, announced that its Zepzelca (Lurbinectedin) has received FDA approval for the treatment of adult patients with metastatic small cell lung cancer (SCLC) who have disease progression on or after platinum-based chemotherapy.

Summary of Key Findings

  • The high manufacturing costs of oligonucleotide APIs limit industry growth
  • Market segmented By Type of Oligonucleotide, End-Use Application, Molecule Size, Modified vs. Unmodified Oligonucleotides, Route of Administration, End-User and region
  • Small oligonucleotides have gained significant market traction
  • Parenteral administration accounts for the majority of the Oligonucleotide API market
  • North America is leading market growth; the market is highly competitive with key players including Jazz Pharmaceuticals, Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics, Alnylam Pharmaceuticals

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Future Outlook

  • Increasing need for oligonucleotide-based therapeutics and diagnostics
  • Technological advancements driving market expansion
  • Increased R&D activity
  • Increasing need for personalized medicine
  • Potential for new applications and therapeutic areas

Segmentation

By Type of Oligonucleotide:

  • Antisense Oligonucleotides (ASOs)
  • RNA Interference (RNAi) Oligonucleotides
  • Messenger RNA (mRNA) Oligonucleotides
  • Modified Oligonucleotides
  • Small Interfering RNA (siRNA)

By Application:

  • Rare Diseases
  • Oncology
  • Neurological Disorders
  • Infectious Diseases
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Others

By Molecule Size:

  • Small Oligonucleotides
  • Long Oligonucleotides

By Modified vs. Unmodified Oligonucleotides:

  • Modified Oligonucleotides
  • Unmodified Oligonucleotides

By Route of Administration:

  • Parenteral Administration
  • Oral Administration
  • Topical and Local Administration

By End-User:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Academic and Research Institutions
  • By Region
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa

Adjacent Markets

In the Oligonucleotide API Market, there are several adjacent markets which has high revenue growth opportunities. The key adjacent markets for Oligonucleotide API Market-

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

 

2. Executive Summary

2.1. Market Snapshot: Global Oligonucleotide API Market

2.1.1. Global Oligonucleotide API Market, By Type of Oligonucleotide

2.1.2. Global Oligonucleotide API Market, By Application

2.1.3. Global Oligonucleotide API Market, By Molecule Size

2.1.4. Global Oligonucleotide API Market, By Modified vs. Unmodified Oligonucleotides

2.1.5. Global Oligonucleotide API Market, By Route of Administration

2.1.6. Global Oligonucleotide API Market, By End-User

2.1.7. Global Oligonucleotide API Market, By Region

2.2. Insights from Primary Respondents

 

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Oligonucleotide API Market Value, 2017-2030, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Oligonucleotide API Market Drivers

3.2.2. Fiberglass Electrical Enclosure Market Restraints

3.2.3. Fiberglass Electrical Enclosure Market Opportunities

3.2.4. Major Fiberglass Electrical Enclosure Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Type of Oligonucleotide

3.5.2. Size

3.5.3. Molecule Size

3.5.4. Modified vs. Unmodified Oligonucleotides

3.5.5. Route of Administration

3.5.6. End-User

3.5.7. Geography

 

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2022

4.1.1. Global Oligonucleotide API Market: Company Market Share, Value 2022

4.1.2. Global Oligonucleotide API Market: Top 6 Company Market Share, Value 2022

4.1.3. Global Oligonucleotide API Market: Top 3 Company Market Share, Value 2022

4.2. Global Oligonucleotide API Market: Company Revenue Share Analysis, 2022

4.3. Company Assessment Metrics, 2022

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/ SMEs Assessment Metrics, 2022

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Product Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Product Matrix

4.7. Potential for New Players in the Global Oligonucleotide API Market

 

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Type of Oligonucleotides

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Research and development in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

 

6. Market Positioning of Key Players, 2022

6.1. Company market share of key players, 2022

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Product Launch

6.5.5. Geographical Expansion

6.5.6. Others

 

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Oligonucleotide API Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Product Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

 

8. Global Oligonucleotide API Market, By Type of Oligonucleotide

8.1. Global Oligonucleotide API Market Overview, by Type of Oligonucleotide

8.1.1. Global Oligonucleotide API Market Revenue Share, By Type of Oligonucleotide, 2022 Vs 2030 (in %)

8.2. Antisense Oligonucleotides (ASOs)

8.2.1. Global Oligonucleotide API Market, By ANTISENSE OLIGONUCLEOTIDES (ASOS), By Region, 2017-2030 (US$ Mn)

8.2.2. Market Dynamics for ANTISENSE OLIGONUCLEOTIDES (ASOS)

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. RNA Interference (RNAi) Oligonucleotides

8.3.1. Global Oligonucleotide API Market, By RNA INTERFERENCE (RNAI) OLIGONUCLEOTIDES, By Region, 2017-2030 (US$ Mn)

8.3.2. Market Dynamics for RNA INTERFERENCE (RNAI) OLIGONUCLEOTIDES

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

8.4. Messenger RNA (mRNA) Oligonucleotides

8.4.1. Global Oligonucleotide API Market, By Messenger RNA (mRNA) Oligonucleotides, By Region, 2017-2030 (US$ Mn)

8.4.2. Market Dynamics for Messenger RNA (mRNA) Oligonucleotides

8.4.2.1. Drivers

8.4.2.2. Restraints

8.4.2.3. Opportunities

8.4.2.4. Trends

8.5. Modified Oligonucleotides

8.5.1. Global Oligonucleotide API Market, By Modified Oligonucleotides, By Region, 2017-2030 (US$ Mn)

8.5.2. Market Dynamics for Modified Oligonucleotides

8.5.2.1. Drivers

8.5.2.2. Restraints

8.5.2.3. Opportunities

8.5.2.4. Trends

8.6. Small Interfering RNA (siRNA)

8.6.1. Global Oligonucleotide API Market, By Small Interfering RNA (siRNA), By Region, 2017-2030 (US$ Mn)

8.6.2. Market Dynamics for Small Interfering RNA (siRNA)

8.6.2.1. Drivers

8.6.2.2. Restraints

8.6.2.3. Opportunities

8.6.2.4. Trends

 

9. Global Oligonucleotide API Market, By Application

9.1. Global Oligonucleotide API Market Overview, By Application

9.1.1. Global Oligonucleotide API Market Revenue Share, By Application, 2022 Vs 2030 (in %)

9.2. Rare Diseases

9.2.1. Global Oligonucleotide API Market, By Rare Diseases, By Region, 2017-2030 (US$ Mn)

9.2.2. Market Dynamics for Rare Diseases

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. Oncology

9.3.1. Global Oligonucleotide API Market, By Oncology, By Region, 2017-2030 (US$ Mn)

9.3.2. Market Dynamics for Oncology

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

9.4. Neurological Disorders

9.4.1. Global Oligonucleotide API Market, By Neurological Disorders, By Region, 2017-2030 (US$ Mn)

9.4.2. Market Dynamics for Neurological Disorders

9.4.2.1. Drivers

9.4.2.2. Restraints

9.4.2.3. Opportunities

9.4.2.4. Trends

9.5. Infectious Diseases

9.5.1. Global Oligonucleotide API Market, By Infectious Diseases, By Region, 2017-2030 (US$ Mn)

9.5.2. Market Dynamics for Infectious Diseases

9.5.2.1. Drivers

9.5.2.2. Restraints

9.5.2.3. Opportunities

9.5.2.4. Trends

9.6. Cardiovascular Diseases

9.6.1. Global Oligonucleotide API Market, By Cardiovascular Diseases, By Region, 2017-2030 (US$ Mn)

9.6.2. Market Dynamics for Cardiovascular Diseases

9.6.2.1. Drivers

9.6.2.2. Restraints

9.6.2.3. Opportunities

9.6.2.4. Trends

9.7. Autoimmune Diseases

9.7.1. Global Oligonucleotide API Market, By Autoimmune Diseases, By Region, 2017-2030 (US$ Mn)

9.7.2. Market Dynamics for Autoimmune Diseases

9.7.2.1. Drivers

9.7.2.2. Restraints

9.7.2.3. Opportunities

9.7.2.4. Trends

9.8. Others

9.8.1. Global Oligonucleotide API Market, By Others, By Region, 2017-2030 (US$ Mn)

9.8.2. Market Dynamics for Others

9.8.2.1. Drivers

9.8.2.2. Restraints

9.8.2.3. Opportunities

9.8.2.4. Trends

 

10. Global Oligonucleotide API Market, By Molecule Size

10.1. Global Oligonucleotide API Market Overview, by Molecule Size

10.1.1. Global Oligonucleotide API Market Revenue Share, By Molecule Size, 2022 Vs 2030 (in %)

10.2. Small Oligonucleotides

10.2.1. Global Oligonucleotide API Market, By Small Oligonucleotides, By Region, 2017-2030 (US$ Mn)

10.2.2. Market Dynamics for Small Oligonucleotides

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. Long Oligonucleotides

10.3.1. Global Oligonucleotide API Market, By Long Oligonucleotides, By Region, 2017-2030 (US$ Mn)

10.3.2. Market Dynamics for Long Oligonucleotides

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

 

11. Global Oligonucleotide API Market, By Modified vs. Unmodified Oligonucleotides

11.1. Global Oligonucleotide API Market Overview, by Modified vs. Unmodified Oligonucleotides

11.1.1. Global Oligonucleotide API Market Revenue Share, By Modified vs. Unmodified Oligonucleotides, 2022 Vs 2030 (in %)

11.2. Modified Oligonucleotides

11.2.1. Global Oligonucleotide API Market, By Modified Oligonucleotides, By Region, 2017-2030 (US$ Mn)

11.2.2. Market Dynamics for Modified Oligonucleotides

11.2.2.1. Drivers

11.2.2.2. Restraints

11.2.2.3. Opportunities

11.2.2.4. Trends

11.3. Unmodified Oligonucleotides

11.3.1. Global Oligonucleotide API Market, By Unmodified Oligonucleotides, By Region, 2017-2030 (US$ Mn)

11.3.2. Market Dynamics for Unmodified Oligonucleotides

11.3.2.1. Drivers

11.3.2.2. Restraints

11.3.2.3. Opportunities

11.3.2.4. Trends

 

12. Global Oligonucleotide API Market, By Route of Administration

12.1. Global Oligonucleotide API Market Overview, by Route of Administration

12.1.1. Global Oligonucleotide API Market Revenue Share, By Route of Administration, 2022 Vs 2030 (in %)

12.2. Parenteral Administration

12.2.1. Global Oligonucleotide API Market, By Parenteral Administration, By Region, 2017-2030 (US$ Mn)

12.2.2. Market Dynamics for Parenteral Administration

12.2.2.1. Drivers

12.2.2.2. Restraints

12.2.2.3. Opportunities

12.2.2.4. Trends

12.3. Oral Administration

12.3.1. Global Oligonucleotide API Market, By  Oral Administration, By Region, 2017-2030 (US$ Mn)

12.3.2. Market Dynamics for  Oral Administration

12.3.2.1. Drivers

12.3.2.2. Restraints

12.3.2.3. Opportunities

12.3.2.4. Trends

12.4. Topical and Local Administration

12.4.1. Global Oligonucleotide API Market, By  Topical and Local Administration, By Region, 2017-2030 (US$ Mn)

12.4.2. Market Dynamics for  Topical and Local Administration

12.4.2.1. Drivers

12.4.2.2. Restraints

12.4.2.3. Opportunities

12.4.2.4. Trends

 

13. Global Oligonucleotide API Market, By End-User

13.1. Global Oligonucleotide API Market Overview, by End-User

13.1.1. Global Oligonucleotide API Market Revenue Share, By End-User, 2022 Vs 2030 (in %)

13.2. Pharmaceutical Companies

13.2.1. Global Oligonucleotide API Market, By Pharmaceutical Companies, By Region, 2017-2030 (US$ Mn)

13.2.2. Market Dynamics for Pharmaceutical Companies

13.2.2.1. Drivers

13.2.2.2. Restraints

13.2.2.3. Opportunities

13.2.2.4. Trends

13.3. Biotechnology Companies

13.3.1. Global Oligonucleotide API Market, By Biotechnology Companies, By Region, 2017-2030 (US$ Mn)

13.3.2. Market Dynamics for Biotechnology Companies

13.3.2.1. Drivers

13.3.2.2. Restraints

13.3.2.3. Opportunities

13.3.2.4. Trends

13.4. Contract Development and Manufacturing Organizations (CDMOs)

13.4.1. Global Oligonucleotide API Market, By Contract Development and Manufacturing Organizations (CDMOs), By Region, 2017-2030 (US$ Mn)

13.4.2. Market Dynamics for Contract Development and Manufacturing Organizations (CDMOs)

13.4.2.1. Drivers

13.4.2.2. Restraints

13.4.2.3. Opportunities

13.4.2.4. Trends

13.5. Academic and Research Institutions

13.5.1. Global Oligonucleotide API Market, By Academic and Research Institutions, By Region, 2017-2030 (US$ Mn)

13.5.2. Market Dynamics for Academic and Research Institutions

13.5.2.1. Drivers

13.5.2.2. Restraints

13.5.2.3. Opportunities

13.5.2.4. Trends

 

14. Global Oligonucleotide API Market, By Region

14.1. Global Oligonucleotide API Market Overview, by Region

14.1.1. Global Oligonucleotide API Market, By Region, 2022 vs 2030 (in%)

14.2. Type of Oligonucleotide

14.2.1. Global Oligonucleotide API Market, By Type of Oligonucleotide, 2017-2030 (US$ Mn)

14.3. Application

14.3.1. Global Oligonucleotide API Market, By Application, 2017-2030 (US$ Mn)

14.4. Molecule Size

14.4.1. Global Oligonucleotide API Market, By Molecule Size, 2017-2030 (US$ Mn)

14.5. Modified vs. Unmodified Oligonucleotides

14.5.1. Global Oligonucleotide API Market, By Modified vs. Unmodified Oligonucleotides, 2017-2030 (US$ Mn)

14.6. Route of Administration

14.6.1. Global Oligonucleotide API Market, By Route of Administration, 2017-2030 (US$ Mn)

14.7. End-User

14.7.1. Global Oligonucleotide API Market, By End-User, 2017-2030 (US$ Mn)

 

15. North America Oligonucleotide API Market Analysis

15.1. Overview

15.1.1. Market Dynamics for North America

15.1.1.1. Drivers

15.1.1.2. Restraints

15.1.1.3. Opportunities

15.1.1.4. Trends

15.2. North America Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2030(US$ Mn)

15.2.1. Overview

15.2.2. SRC Analysis

15.3. North America Oligonucleotide API Market, By Application, 2017-2030(US$ Mn)

15.3.1. Overview

15.3.2. SRC Analysis

15.4. North America Oligonucleotide API Market, by Molecule Size, 2017-2030(US$ Mn)

15.4.1. Overview

15.4.2. SRC Analysis

15.5. North America Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, 2017-2030(US$ Mn)

15.5.1. Overview

15.5.2. SRC Analysis

15.6. North America Oligonucleotide API Market, by Route of Administration, 2017-2030(US$ Mn)

15.6.1. Overview

15.6.2. SRC Analysis

15.7. North America Oligonucleotide API Market, by End-User, 2017-2030(US$ Mn)

15.7.1. Overview

15.7.2. SRC Analysis

15.8. North America Oligonucleotide API Market, by Country, 2017-2030(US$ Mn)

15.8.1. North America Oligonucleotide API Market, by Country, 2022 Vs 2030 (in%)

15.8.2. U.S.

15.8.3. Canada

15.8.4. Mexico

 

16. Europe Oligonucleotide API Market Analysis

16.1. Overview

16.1.1. Market Dynamics for North America

16.1.1.1. Drivers

16.1.1.2. Restraints

16.1.1.3. Opportunities

16.1.1.4. Trends

16.2. Europe Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2030(US$ Mn)

16.2.1. Overview

16.2.2. SRC Analysis

16.3. Europe Oligonucleotide API Market, By Application, 2017-2030(US$ Mn)

16.3.1. Overview

16.3.2. SRC Analysis

16.4. Europe Oligonucleotide API Market, by Molecule Size, 2017-2030(US$ Mn)

16.4.1. Overview

16.4.2. SRC Analysis

16.5. Europe Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, 2017-2030(US$ Mn)

16.5.1. Overview

16.5.2. SRC Analysis

16.6. Europe Oligonucleotide API Market, by Route of Administration, 2017-2030(US$ Mn)

16.6.1. Overview

16.6.2. SRC Analysis

16.7. Europe Oligonucleotide API Market, by End-User, 2017-2030(US$ Mn)

16.7.1. Overview

16.7.2. SRC Analysis

16.8. Europe Oligonucleotide API Market, by Country, 2017-2030 (US$ Mn)

16.8.1. Europe Oligonucleotide API Market, by Country, 2022 Vs 2030 (in%)

16.8.2. UK

16.8.3. France

16.8.4. Germany

16.8.5. Italy

16.8.6. Spain

16.8.7. Benelux

16.8.8. Russia

16.8.9. Rest of Europe

 

17. Asia Pacific Oligonucleotide API Market Analysis

17.1. Overview

17.1.1. Market Dynamics for North America

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. Asia Pacific Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2030(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. Asia Pacific Oligonucleotide API Market, By Application, 2017-2030(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. Asia Pacific Oligonucleotide API Market, by Molecule Size, 2017-2030(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. Asia PacificOligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, 2017-2030(US$ Mn)

17.5.1. Overview

17.5.2. SRC Analysis

17.6. Asia Pacific Oligonucleotide API Market, by Route of Administration, 2017-2030(US$ Mn)

17.6.1. Overview

17.6.2. SRC Analysis

17.7. Asia Pacific Oligonucleotide API Market, by End-User, 2017-2030(US$ Mn)

17.7.1. Overview

17.7.2. SRC Analysis

17.8. Asia Pacific Oligonucleotide API Market, by Country, 2017-2030 (US$ Mn)

17.8.1. Asia Pacific Oligonucleotide API Market, by Country, 2022 Vs 2030 (in%)

17.8.2. China

17.8.3. Japan

17.8.4. India

17.8.5. South Korea

17.8.6. South East Asia

17.8.7. Rest of Asia Pacific

 

18. Latin America Oligonucleotide API Market Analysis

18.1. Overview

18.1.1. Market Dynamics for North America

18.1.1.1. Drivers

18.1.1.2. Restraints

18.1.1.3. Opportunities

18.1.1.4. Trends

18.2. Latin America Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2030(US$ Mn)

18.2.1. Overview

18.2.2. SRC Analysis

18.3. Latin America Oligonucleotide API Market, By Application, 2017-2030(US$ Mn)

18.3.1. Overview

18.3.2. SRC Analysis

18.4. Latin America Oligonucleotide API Market, by Molecule Size, 2017-2030(US$ Mn)

18.4.1. Overview

18.4.2. SRC Analysis

18.5. Latin AmericaOligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, 2017-2030(US$ Mn)

18.5.1. Overview

18.5.2. SRC Analysis

18.6. Latin AmericaOligonucleotide API Market, by Route of Administration, 2017-2030(US$ Mn)

18.6.1. Overview

18.6.2. SRC Analysis

18.7. Latin America Oligonucleotide API Market, by End-User, 2017-2030(US$ Mn)

18.7.1. Overview

18.7.2. SRC Analysis

18.8. Latin America Oligonucleotide API Market, by Country, 2017-2030 (US$ Mn)

18.8.1. Latin America Oligonucleotide API Market, by Country, 2022 Vs 2030 (in%)

18.8.2. Brazil

18.8.3. Argentina

18.8.4. Rest of Latin America

 

19. Middle East Oligonucleotide API Market Analysis

19.1. Overview

19.1.1. Market Dynamics for North America

19.1.1.1. Drivers

19.1.1.2. Restraints

19.1.1.3. Opportunities

19.1.1.4. Trends

19.2. Middle East Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2030(US$ Mn)

19.2.1. Overview

19.2.2. SRC Analysis

19.3. Middle East Oligonucleotide API Market, By Application, 2017-2030(US$ Mn)

19.3.1. Overview

19.3.2. SRC Analysis

19.4. Middle EastOligonucleotide API Market, by Molecule Size, 2017-2030(US$ Mn)

19.4.1. Overview

19.4.2. SRC Analysis

19.5. Middle East Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, 2017-2030(US$ Mn)

19.5.1. Overview

19.5.2. SRC Analysis

19.6. Middle East Oligonucleotide API Market, by Route of Administration, 2017-2030(US$ Mn)

19.6.1. Overview

19.6.2. SRC Analysis

19.7. Middle East Oligonucleotide API Market, by End-User, 2017-2030(US$ Mn)

19.7.1. Overview

19.7.2. SRC Analysis

19.8. Middle East Oligonucleotide API Market, by Country, 2017-2030 (US$ Mn)

19.8.1. Middle East Oligonucleotide API Market, by Country, 2022 Vs 2030 (in%)

19.8.2. UAE

19.8.3. Saudi Arabia

19.8.4. Rest of Middle East

 

20. Africa Oligonucleotide API Market Analysis

20.1. Overview

20.1.1. Market Dynamics for North America

20.1.1.1. Drivers

20.1.1.2. Restraints

20.1.1.3. Opportunities

20.1.1.4. Trends

20.2. Africa Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2030(US$ Mn)

20.2.1. Overview

20.2.2. SRC Analysis

20.3. Africa Oligonucleotide API Market, By Application, 2017-2030(US$ Mn)

20.3.1. Overview

20.3.2. SRC Analysis

20.4. Africa Oligonucleotide API Market, by Molecule Size, 2017-2030(US$ Mn)

20.4.1. Overview

20.4.2. SRC Analysis

20.5. Africa Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, 2017-2030(US$ Mn)

20.5.1. Overview

20.5.2. SRC Analysis

20.6. Africa Oligonucleotide API Market, by Route of Administration, 2017-2030(US$ Mn)

20.6.1. Overview

20.6.2. SRC Analysis

20.7. Africa Oligonucleotide API Market, by End-User, 2017-2030(US$ Mn)

20.7.1. Overview

20.7.2. SRC Analysis

20.8. Africa Oligonucleotide API Market, by Country, 2017-2030 (US$ Mn)

20.8.1. Middle East Oligonucleotide API Market, by Country, 2022 Vs 2030 (in%)

20.8.2. South Africa

20.8.3. Egypt

20.8.4. Rest of Africa

 

21. Company Profiles

21.1. Jazz Pharmaceuticals

21.1.1. Company Overview

21.1.2. Products/Services Portfolio

21.1.3. Geographical Presence

21.1.4. SWOT Analysis

21.1.5. Financial Summary

21.1.5.1. Market Revenue and Net Profit (2019-2022)

21.1.5.2. Business Segment Revenue Analysis

21.1.5.3. Geographical Revenue Analysis

21.2. Sarepta Therapeutics

21.3. Biogen

21.4. Dynavax Technologies

21.5. Akcea Therapeutics

21.6. Alnylam Pharmaceuticals

21.7. Nitto Denko (Avecia)

21.8. Ajinomoto (GeneDesign)

21.9. RiboBio

 

22. Research Methodology

22.1. Research Methodology

22.2. Phase I – Secondary Research

22.3. Phase II – Data Modelling

22.3.1. Company Share Analysis Model

22.3.2. Revenue Based Modelling

22.4. Phase III – Primary Research

22.5. Research Limitations

22.5.1. Assumptions

List of Figures

FIG. 1 Global Oligonucleotide API Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom up Approach

FIG. 3 Global Oligonucleotide API Market Segmentation

FIG. 4 Global Oligonucleotide API Market, by Type of Oligonucleotide, 2022 (US$ Mn)

FIG. 5 Global Oligonucleotide API Market, By Application, 2022 (US$ Mn)

FIG. 6 Global Oligonucleotide API Market, by Molecule Size, 2022 (US$ Mn)

FIG. 7 Global Oligonucleotide API Market, by Data Trasnfer Speed, 2022 (US$ Mn)

FIG. 8 Global Oligonucleotide API Market, by Route of Administration, 2022 (US$ Mn)

FIG. 9 Global Oligonucleotide API Market, by End-User, 2022 (US$ Mn)

FIG. 10 Global Oligonucleotide API Market, by Geography, 2022 (US$ Mn)

FIG. 11 Attractive Investment Proposition, by Type of Oligonucleotide, 2022

FIG. 12 Attractive Investment Proposition, By Application, 2022

FIG. 13 Attractive Investment Proposition, by Molecule Size, 2022

FIG. 14 Attractive Investment Proposition, by Modified vs. Unmodified Oligonucleotides, 2022

FIG. 15 Attractive Investment Proposition, by Route of Administration, 2022

FIG. 16 Attractive Investment Proposition, by End-User, 2022

FIG. 17 Attractive Investment Proposition, by Geography, 2022

FIG. 18 Global Market Share Analysis of Key Oligonucleotide API Market Manufacturers, 2022

FIG. 19 Global Market Positioning of Key Oligonucleotide API Market Manufacturers, 2022

FIG. 20 Global Oligonucleotide API Market Value Contribution, By Type of Oligonucleotide, 2022 & 2030 (Value %)

FIG. 21 Global Oligonucleotide API Market, by ANTISENSE OLIGONUCLEOTIDES (ASOS), Value, 2017-2030 (US$ Mn)

FIG. 22 Global Oligonucleotide API Market, by RNA INTERFERENCE (RNAI) OLIGONUCLEOTIDES, Value, 2017-2030 (US$ Mn)

FIG. 23 Global Oligonucleotide API Market, by Messenger RNA (mRNA) Oligonucleotides, Value, 2017-2030 (US$ Mn)

FIG. 24 Global Oligonucleotide API Market, by Modified Oligonucleotides, Value, 2017-2030 (US$ Mn)

FIG. 25 Global Oligonucleotide API Market, by Small Interfering RNA (siRNA), Value, 2017-2030 (US$ Mn)

FIG. 26 Global Oligonucleotide API Market Value Contribution, By Application, 2022 & 2030 (Value %)

FIG. 27 Global Oligonucleotide API Market, by Rare Diseases, Value, 2017-2030 (US$ Mn)

FIG. 28 Global Oligonucleotide API Market, by Oncology, Value, 2017-2030 (US$ Mn)

FIG. 29 Global Oligonucleotide API Market, by Neurological Disorders, Value, 2017-2030 (US$ Mn)

FIG. 30 Global Oligonucleotide API Market, by Infectious Diseases, Value, 2017-2030 (US$ Mn)

FIG. 31 Global Oligonucleotide API Market, by Cardiovascular Diseases, Value, 2017-2030 (US$ Mn)

FIG. 32 Global Oligonucleotide API Market, by Autoimmune Diseases, Value, 2017-2030 (US$ Mn)

FIG. 33 Global Oligonucleotide API Market, by Others, Value, 2017-2030 (US$ Mn)

FIG. 34 Global Oligonucleotide API Market Value Contribution, By Molecule Size, 2022 & 2030 (Value %)

FIG. 35 Global Oligonucleotide API Market, by Small Oligonucleotides, Value, 2017-2030 (US$ Mn)

FIG. 36 Global Oligonucleotide API Market, by Long Oligonucleotides, Value, 2017-2030 (US$ Mn)

FIG. 37 Global Oligonucleotide API Market Value Contribution, By Modified vs. Unmodified Oligonucleotides, 2022 & 2030 (Value %)

FIG. 38 Global Oligonucleotide API Market, by Modified Oligonucleotides, Value, 2017-2030 (US$ Mn)

FIG. 39 Global Oligonucleotide API Market, by Unmodified Oligonucleotides, Value, 2017-2030 (US$ Mn)

FIG. 40 Global Oligonucleotide API Market Value Contribution, By Route of Administration, 2022 & 2030 (Value %)

FIG. 41 Global Oligonucleotide API Market, by Parenteral Administration, Value, 2017-2030 (US$ Mn)

FIG. 42 Global Oligonucleotide API Market, by  Oral Administration, Value, 2017-2030 (US$ Mn)

FIG. 43 Global Oligonucleotide API Market, by  Topical and Local Administration, Value, 2017-2030 (US$ Mn)

FIG. 44 Global Oligonucleotide API Market Value Contribution, By End-User, 2022 & 2030 (Value %)

FIG. 45 Global Oligonucleotide API Market, by Pharmaceutical Companies, Value, 2017-2030 (US$ Mn)

FIG. 46 Global Oligonucleotide API Market, by Biotechnology Companies, Value, 2017-2030 (US$ Mn)

FIG. 47 Global Oligonucleotide API Market, by Contract Development and Manufacturing Organizations (CDMOs), Value, 2017-2030 (US$ Mn)

FIG. 48 Global Oligonucleotide API Market, by Academic and Research Institutions, Value, 2017-2030 (US$ Mn)

FIG. 49 North America Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 50 U.S. Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 51 Canada Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 52 Mexico Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 53 Europe Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 54 Germany Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 55 France Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 56 U.K. Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 57 Italy Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 58 Spain Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 59 Benelux Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 60 Russia Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 61 Rest of Europe Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 62 Asia Pacific Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 63 China Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 64 Japan Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 65 India Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 66 South Korea Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 67 South-East Asia Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 68 Rest of Asia Pacific Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 69 Latin America Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 70 Brazil Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 71 Argentina Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 72 Rest of Latin America Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 73 Middle East Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 74 UAE Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 75 Saudi Arabia Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 76 Rest of Middle East Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 77 Africa Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 78 South Africa Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 79 Egypt Oligonucleotide API Market, 2017-2030 (US$ Mn)

FIG. 80 Rest of Africa Oligonucleotide API Market, 2017-2030 (US$ Mn)

 

List of Tables

TABLE 1 Market Snapshot: Global  Oligonucleotide API Market

TABLE 2 Global  Oligonucleotide API Market: Market Drivers Impact Analysis

TABLE 3 Global  Oligonucleotide API Market: Market Restraints Impact Analysis

TABLE 4 Global  Oligonucleotide API Market, by Competitive Benchmarking, 2022

TABLE 5 Global  Oligonucleotide API Market, by Geographical Presence Analysis, 2022

TABLE 6 Global  Oligonucleotide API Market, by Key Strategies Analysis, 2022

TABLE 7 Global  Oligonucleotide API Market, by ANTISENSE OLIGONUCLEOTIDES (ASOS), By Region, 2017-2022 (US$ Mn)

TABLE 8 Global  Oligonucleotide API Market, by ANTISENSE OLIGONUCLEOTIDES (ASOS), By Region, 2023-2030 (US$ Mn)

TABLE 9 Global  Oligonucleotide API Market, by RNA INTERFERENCE (RNAI) OLIGONUCLEOTIDES, By Region, 2017-2022 (US$ Mn)

TABLE 10 Global  Oligonucleotide API Market, by RNA INTERFERENCE (RNAI) OLIGONUCLEOTIDES, By Region, 2023-2030 (US$ Mn)

TABLE 11 Global  Oligonucleotide API Market, by Messenger RNA (mRNA) Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 12 Global  Oligonucleotide API Market, by Messenger RNA (mRNA) Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 13 Global  Oligonucleotide API Market, by Modified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 14 Global  Oligonucleotide API Market, by Modified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 15 Global  Oligonucleotide API Market, by Small Interfering RNA (siRNA), By Region, 2017-2022 (US$ Mn)

TABLE 16 Global  Oligonucleotide API Market, by Small Interfering RNA (siRNA), By Region, 2023-2030 (US$ Mn)

TABLE 17 Global  Oligonucleotide API Market, by Rare Diseases, By Region, 2017-2022 (US$ Mn)

TABLE 18 Global  Oligonucleotide API Market, by Rare Diseases, By Region, 2023-2030 (US$ Mn)

TABLE 19 Global  Oligonucleotide API Market, by Oncology, By Region, 2017-2022 (US$ Mn)

TABLE 20 Global  Oligonucleotide API Market, by Oncology, By Region, 2023-2030 (US$ Mn)

TABLE 21 Global  Oligonucleotide API Market, by Neurological Disorders, By Region, 2017-2022 (US$ Mn)

TABLE 22 Global  Oligonucleotide API Market, by Neurological Disorders, By Region, 2023-2030 (US$ Mn)

TABLE 23 Global  Oligonucleotide API Market, by Infectious Diseases, By Region, 2017-2022 (US$ Mn)

TABLE 24 Global  Oligonucleotide API Market, by Infectious Diseases, By Region, 2023-2030 (US$ Mn)

TABLE 25 Global  Oligonucleotide API Market, by Cardiovascular Diseases, By Region, 2017-2022 (US$ Mn)

TABLE 26 Global  Oligonucleotide API Market, by Cardiovascular Diseases, By Region, 2023-2030 (US$ Mn)

TABLE 27 Global  Oligonucleotide API Market, by Autoimmune Diseases, By Region, 2017-2022 (US$ Mn)

TABLE 28 Global  Oligonucleotide API Market, by Autoimmune Diseases, By Region, 2023-2030 (US$ Mn)

TABLE 29 Global  Oligonucleotide API Market, by Others, By Region, 2017-2022 (US$ Mn)

TABLE 30 Global  Oligonucleotide API Market, by Others, By Region, 2023-2030 (US$ Mn)

TABLE 31 Global  Oligonucleotide API Market, by Small Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 32 Global  Oligonucleotide API Market, by Small Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 33 Global  Oligonucleotide API Market, by Long Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 34 Global  Oligonucleotide API Market, by Long Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 35 Global  Oligonucleotide API Market, by Modified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 36 Global  Oligonucleotide API Market, by Modified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 37 Global  Oligonucleotide API Market, by Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 38 Global  Oligonucleotide API Market, by Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 39 Global  Oligonucleotide API Market, by Parenteral Administration, By Region, 2023-2030 (US$ Mn)

TABLE 40 Global  Oligonucleotide API Market, by Parenteral Administration, By Region, 2017-2022 (US$ Mn)

TABLE 41 Global  Oligonucleotide API Market, by  Oral Administration, By Region, 2023-2030 (US$ Mn)

TABLE 42 Global  Oligonucleotide API Market, by  Oral Administration, By Region, 2017-2022 (US$ Mn)

TABLE 43 Global  Oligonucleotide API Market, by  Topical and Local Administration, By Region, 2023-2030 (US$ Mn)

TABLE 44 Global  Oligonucleotide API Market, by  Topical and Local Administration, By Region, 2017-2022 (US$ Mn)

TABLE 45 Global  Oligonucleotide API Market, by Pharmaceutical Companies, By Region, 2017-2022 (US$ Mn)

TABLE 46 Global  Oligonucleotide API Market, by Pharmaceutical Companies, By Region, 2023-2030 (US$ Mn)

TABLE 47 Global  Oligonucleotide API Market, by Biotechnology Companies, By Region, 2017-2022 (US$ Mn)

TABLE 48 Global  Oligonucleotide API Market, by Biotechnology Companies, By Region, 2023-2030 (US$ Mn)

TABLE 49 Global  Oligonucleotide API Market, by Contract Development and Manufacturing Organizations (CDMOs), By Region, 2017-2022 (US$ Mn)

TABLE 50 Global  Oligonucleotide API Market, by Contract Development and Manufacturing Organizations (CDMOs), By Region, 2023-2030 (US$ Mn)

TABLE 51 Global  Oligonucleotide API Market, by Academic and Research Institutions, By Region, 2017-2022 (US$ Mn)

TABLE 52 Global  Oligonucleotide API Market, by Academic and Research Institutions, By Region, 2023-2030 (US$ Mn)

TABLE 53 Global  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 54 Global  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 55 Global  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 56 Global  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 57 Global  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 58 Global  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 59 Global  Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 60 Global  Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 61 Global  Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 62 Global  Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 63 Global  Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 64 Global  Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 65 Global  Oligonucleotide API Market, by Region, 2017-2022 (US$ Mn)

TABLE 66 Global  Oligonucleotide API Market, by Region, 2023-2030 (US$ Mn)

TABLE 67 North America  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 68 North America  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 69 North America  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 70 North America  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 71 North America  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 72 North America  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 73 North America Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 74 North America Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 75 North America Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 76 North America Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 77 North America Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 78 North America Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 79 North America  Oligonucleotide API Market, by Country, 2017-2022 (US$ Mn)

TABLE 80 North America  Oligonucleotide API Market, by Country, 2023-2030 (US$ Mn)

TABLE 81 United States  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 82 United States  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 83 United States  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 84 United States  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 85 United States  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 86 United States  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 87 United States Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 88 United States Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 89 United States Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 90 United States Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 91 United States Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 92 United States Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 93 Canada  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 94 Canada  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 95 Canada  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 96 Canada  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 97 Canada  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 98 Canada  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 99 Canada Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 100 Canada Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 101 Canada Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 102 Canada Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 103 Canada Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 104 Canada Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 105 Mexico  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 106 Mexico  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 107 Mexico  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 108 Mexico  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 109 Mexico  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 110 Mexico  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 111 Mexico Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 112 Mexico Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 113 Mexico Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 114 Mexico Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 115 Mexico Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 116 Mexico Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 117 Europe  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 118 Europe  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 119 Europe  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 120 Europe  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 121 Europe  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 122 Europe  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 123 Europe Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 124 Europe Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 125 Europe Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 126 Europe Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 127 Europe Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 128 Europe Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 129 Europe  Oligonucleotide API Market, by Country, 2017-2022 (US$ Mn)

TABLE 130 Europe  Oligonucleotide API Market, by Country, 2023-2030 (US$ Mn)

TABLE 131 Germany  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 132 Germany  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 133 Germany  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 134 Germany  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 135 Germany  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 136 Germany  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 137 Germany Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 138 Germany Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 139 Germany Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 140 Germany Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 141 Germany Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 142 Germany Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 143 France  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 144 France  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 145 France  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 146 France  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 147 France  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 148 France  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 149 France Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 150 France Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 151 France Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 152 France Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 153 France Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 154 France Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 155 United Kingdom  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 156 United Kingdom  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 157 United Kingdom  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 158 United Kingdom  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 159 United Kingdom  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 160 United Kingdom  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 161 United Kingdom Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 162 United Kingdom Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 163 United Kingdom Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 164 United Kingdom Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 165 United Kingdom Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 166 United Kingdom Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 167 Italy  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 168 Italy  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 169 Italy  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 170 Italy  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 171 Italy  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 172 Italy  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 173 Italy Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 174 Italy Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 175 Italy Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 176 Italy Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 177 Italy Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 178 Italy Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 179 Spain  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 180 Spain  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 181 Spain  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 182 Spain  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 183 Spain  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 184 Spain  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 185 Spain Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 186 Spain Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 187 Spain Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 188 Spain Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 189 Spain Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 190 Spain Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 191 Benelux Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 192 Benelux Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 193 Benelux Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 194 Benelux Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 195 Benelux Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 196 Benelux Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 197 Benelux Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 198 Benelux Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 199 Benelux Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 200 Benelux Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 201 Benelux Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 202 Benelux Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 203 Russia Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 204 Russia Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 205 Russia Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 206 Russia Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 207 Russia Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 208 Russia Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 209 Russia Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 210 Russia Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 211 Russia Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 212 Russia Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 213 Russia Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 214 Russia Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 215 Rest of Europe  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 216 Rest of Europe  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 217 Rest of Europe  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 218 Rest of Europe  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 219 Rest of Europe  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 220 Rest of Europe  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 221 Rest of Europe Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 222 Rest of Europe Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 223 Rest of Europe Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 224 Rest of Europe Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 225 Rest of Europe Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 226 Rest of Europe Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 227 Asia Pacific  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 228 Asia Pacific  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 229 Asia Pacific  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 230 Asia Pacific  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 231 Asia Pacific  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 232 Asia Pacific  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 233 Asia Pacific Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 234 Asia Pacific Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 235 Asia Pacific Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 236 Asia Pacific Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 237 Asia Pacific Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 238 Asia Pacific Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 239 China  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 240 China  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 241 China  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 242 China  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 243 China  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 244 China  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 245 China Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 246 China Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 247 China Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 248 China Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 249 China Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 250 China Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 251 Japan  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 252 Japan  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 253 Japan  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 254 Japan  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 255 Japan  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 256 Japan  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 257 Japan Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 258 Japan Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 259 Japan Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 260 Japan Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 261 Japan Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 262 Japan Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 263 India  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 264 India  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 265 India  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 266 India  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 267 India  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 268 India  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 269 India Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 270 India Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 271 India Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 272 India Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 273 India Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 274 India Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 275 South Korea  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 276 South Korea  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 277 South Korea  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 278 South Korea  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 279 South Korea  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 280 South Korea  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 281 South Korea Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 282 South Korea Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 283 South Korea Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 284 South Korea Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 285 South Korea Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 286 South Korea Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 287 South-East Asia  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 288 South-East Asia  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 289 South-East Asia  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 290 South-East Asia  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 291 South-East Asia  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 292 South-East Asia  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 293 South-East Asia Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 294 South-East Asia Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 295 South-East Asia Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 296 South-East Asia Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 297 South-East Asia Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 298 South-East Asia Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 299 Rest of Asia Pacific  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 300 Rest of Asia Pacific  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 301 Rest of Asia Pacific  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 302 Rest of Asia Pacific  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 303 Rest of Asia Pacific  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 304 Rest of Asia Pacific  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 305 Rest of Asia Pacific Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 306 Rest of Asia Pacific Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 307 Rest of Asia Pacific Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 308 Rest of Asia Pacific Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 309 Rest of Asia Pacific Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 310 Rest of Asia Pacific Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 311 Latin America  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 312 Latin America  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 313 Latin America  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 314 Latin America  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 315 Latin America  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 316 Latin America  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 317 Latin America Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 318 Latin America Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 319 Latin America Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 320 Latin America Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 321 Latin America Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 322 Latin America Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 323 Brazil  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 324 Brazil  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 325 Brazil  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 326 Brazil  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 327 Brazil  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 328 Brazil  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 329 Brazil Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 330 Brazil Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 331 Brazil Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 332 Brazil Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 333 Brazil Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 334 Brazil Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 335 Argentina  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 336 Argentina  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 337 Argentina  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 338 Argentina  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 339 Argentina  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 340 Argentina  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 341 Argentina Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 342 Argentina Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 343 Argentina Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 344 Argentina Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 345 Argentina Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 346 Argentina Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 347 Rest of Latin America  Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 348 Rest of Latin America  Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 349 Rest of Latin America  Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 350 Rest of Latin America  Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 351 Rest of Latin America  Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 352 Rest of Latin America  Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 353 Rest of Latin America Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 354 Rest of Latin America Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 355 Rest of Latin America Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 356 Rest of Latin America Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 357 Rest of Latin America Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 358 Rest of Latin America Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 359 Middle East Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 360 Middle East Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 361 Middle East Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 362 Middle East Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 363 Middle East Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 364 Middle East Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 365 Middle East Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 366 Middle East Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 367 Middle East Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 368 Middle East Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 369 Middle East Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 370 Middle East Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 371 UAE Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 372 UAE Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 373 UAE Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 374 UAE Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 375 UAE Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 376 UAE Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 377 UAE Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 378 UAE Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 379 UAE Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 380 UAE Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 381 UAE Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 382 UAE Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 383 Saudi Arabia Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 384 Saudi Arabia Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 385 Saudi Arabia Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 386 Saudi Arabia Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 387 Saudi Arabia Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 388 Saudi Arabia Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 389 Saudi Arabia Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 390 Saudi Arabia Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 391 Saudi Arabia Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 392 Saudi Arabia Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 393 Saudi Arabia Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 394 Saudi Arabia Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 395 Rest of Middle East Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 396 Rest of Middle East Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 397 Rest of Middle East Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 398 Rest of Middle East Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 399 Rest of Middle East Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 400 Rest of Middle East Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 401 Rest of Middle East Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 402 Rest of Middle East Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 403 Rest of Middle East Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 404 Rest of Middle East Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 405 Rest of Middle East Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 406 Rest of Middle East Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 407 Africa Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 408 Africa Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 409 Africa Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 410 Africa Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 411 Africa Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 412 Africa Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 413 Africa Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 414 Africa Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 415 Africa Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 416 Africa Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 417 Africa Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 418 Africa Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 419 South Africa Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 420 South Africa Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 421 South Africa Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 422 South Africa Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 423 South Africa Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 424 South Africa Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 425 South Africa Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 426 South Africa Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 427 South Africa Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 428 South Africa Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 429 South Africa Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 430 South Africa Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 431 Egypt Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 432 Egypt Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 433 Egypt Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 434 Egypt Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 435 Egypt Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 436 Egypt Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 437 Egypt Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 438 Egypt Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 439 Egypt Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 440 Egypt Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 441 Egypt Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 442 Egypt Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

TABLE 443 Rest of Africa Oligonucleotide API Market, by Type of Oligonucleotide, 2017-2022 (US$ Mn)

TABLE 444 Rest of Africa Oligonucleotide API Market, by Type of Oligonucleotide, 2023-2030 (US$ Mn)

TABLE 445 Rest of Africa Oligonucleotide API Market, By Application, 2017-2022 (US$ Mn)

TABLE 446 Rest of Africa Oligonucleotide API Market, By Application, 2023-2030 (US$ Mn)

TABLE 447 Rest of Africa Oligonucleotide API Market, by Molecule Size, 2017-2022 (US$ Mn)

TABLE 448 Rest of Africa Oligonucleotide API Market, by Molecule Size, 2023-2030 (US$ Mn)

TABLE 449 Rest of Africa Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2017-2022 (US$ Mn)

TABLE 450 Rest of Africa Oligonucleotide API Market, by Modified vs. Unmodified Oligonucleotides, By Region, 2023-2030 (US$ Mn)

TABLE 451 Rest of Africa Oligonucleotide API Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 452 Rest of Africa Oligonucleotide API Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 453 Rest of Africa Oligonucleotide API Market, by End-User, 2017-2022 (US$ Mn)

TABLE 454 Rest of Africa Oligonucleotide API Market, by End-User, 2023-2030 (US$ Mn)

Frequently Asked Questions

What is the current Species of the worldwide Oligonucleotide API Market?

In 2022, the global Oligonucleotide API Market is expected to be worth USD 2315.5 million.

What is the predicted growth rate of the Oligonucleotide API Market between 2023 and 2030?

The Oligonucleotide API Market is estimated to increase at a CAGR of 10.60% between 2023 and 2030, reaching USD 5184.2 Million in 2030.

Which segment has the most market share in terms of Application?

Oncology is now the industry leader in the Oligonucleotide APIs market

Which type of vertical transportation equipment segment governs the market demand for Oligonucleotide API ?

Antisense oligonucleotides are expected to account for the majority of revenue

Which application segment is predicted to grow at the fastest growth segment over the forecast period?

Rare diseases are one of the Oligonucleotide API market’s fastest-growing sectors

Which region is driving the Oligonucleotide API  industry forward?

In 2022, North America is the largest region in the Oligonucleotide API North America dominates the Oligonucleotide API Market, accounting for around 45% of the global market share

Who are the major players in the global Oligonucleotide API Market?

The top players include Jazz Pharmaceuticals, Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics, Alnylam Pharmaceuticals

What are the major market drivers of the Oligonucleotide API  industry?

The primary drivers of the market include rising demand for personalized medicine and targeted therapies, advancements in oligonucleotide synthesis technologies and manufacturing processes, and rising investments in research & development of oligonucleotide-based therapeutics.

What are the major market restraints of the Oligonucleotide API  industry?

Stringent regulatory requirements for approval of oligonucleotide-based drugs, High manufacturing costs associated with oligonucleotide APIs and Limited awareness and understanding of oligonucleotide-based therapies among healthcare professionals and patients are the key restraints of the market

What are the major market opportunities of the Oligonucleotide API  industry?

Expansion of applications beyond traditional therapeutic areas, Collaborations and partnerships between pharmaceutical companies and research institutions and Emerging markets and untapped potential for oligonucleotide-based therapies in developing countries are the key opportunities in the market

Digital PCR Market

Published:
Report ID: 12323

In-Vitro ADME Services Market

Published:
Report ID: 11191

Europe Distributed Solar Power Generation Market

Published:
Report ID: 37132

Biotechnology Contract Manufacturing Market

Published:
Report ID: 36713

Cell Culture Media And Reagents Market

Published:
Report ID: 3489

Viral Antigens Market

Published:
Report ID: 36114

Recombinant Protein Market

Published:
Report ID: 35991

Bacteriophage Market

Published:
Report ID: 2114

India Bone Marrow Transplantation (BMT) Market

Published:
Report ID: 35571

Bioengineered Skin And Skin Substitutes Market

Published:
Report ID: 3472

DNA and RNA Sample Preparation Market

Published:
Report ID: 34911

Laboratory Filtration Market

Published:
Report ID: 7940

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN